291 related articles for article (PubMed ID: 36090985)
1. Schlafen family is a prognostic biomarker and corresponds with immune infiltration in gastric cancer.
Xu J; Chen S; Liang J; Hao T; Wang H; Liu G; Jin X; Li H; Zhang J; Zhang C; He Y
Front Immunol; 2022; 13():922138. PubMed ID: 36090985
[TBL] [Abstract][Full Text] [Related]
2. Expression and regulation of Schlafen (SLFN) family members in primary human monocytes, monocyte-derived dendritic cells and T cells.
Puck A; Aigner R; Modak M; Cejka P; Blaas D; Stöckl J
Results Immunol; 2015; 5():23-32. PubMed ID: 26623250
[TBL] [Abstract][Full Text] [Related]
3. Schlafen Family Intra-Regulation by IFN-α2 in Triple-Negative Breast Cancer.
Brown SR; Vomhof-DeKrey EE; Al-Marsoummi S; Brown ND; Hermanson K; Basson MD
Cancers (Basel); 2023 Nov; 15(23):. PubMed ID: 38067362
[TBL] [Abstract][Full Text] [Related]
4. SCHLAFEN 5 expression correlates with intestinal metaplasia that progresses to gastric cancer.
Companioni Nápoles O; Tsao AC; Sanz-Anquela JM; Sala N; Bonet C; Pardo ML; Ding L; Simo O; Saqui-Salces M; Blanco VP; Gonzalez CA; Merchant JL
J Gastroenterol; 2017 Jan; 52(1):39-49. PubMed ID: 27032393
[TBL] [Abstract][Full Text] [Related]
5. Role of interferon {alpha} (IFN{alpha})-inducible Schlafen-5 in regulation of anchorage-independent growth and invasion of malignant melanoma cells.
Katsoulidis E; Mavrommatis E; Woodard J; Shields MA; Sassano A; Carayol N; Sawicki KT; Munshi HG; Platanias LC
J Biol Chem; 2010 Dec; 285(51):40333-41. PubMed ID: 20956525
[TBL] [Abstract][Full Text] [Related]
6. CD44 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
Hou W; Kong L; Hou Z; Ji H
BMC Med Genomics; 2022 Oct; 15(1):225. PubMed ID: 36316684
[TBL] [Abstract][Full Text] [Related]
7. CLEC11A expression as a prognostic biomarker in correlation to immune cells of gastric cancer.
Fang W; Wan D; Yu Y; Zhang L
Biomol Biomed; 2024 Jan; 24(1):101-124. PubMed ID: 37597212
[TBL] [Abstract][Full Text] [Related]
8. YTHDF1 regulates immune cell infiltration in gastric cancer via interaction with p53.
Liao Q; Xiong J
Exp Ther Med; 2024 Jun; 27(6):255. PubMed ID: 38682111
[TBL] [Abstract][Full Text] [Related]
9. Progress in investigating the relationship between Schlafen5 genes and malignant tumors.
Tu T; Yuan Y; Liu X; Liang X; Yang X; Yang Y
Front Oncol; 2023; 13():1248825. PubMed ID: 37771431
[TBL] [Abstract][Full Text] [Related]
10. Structural, molecular, and functional insights into Schlafen proteins.
Jo U; Pommier Y
Exp Mol Med; 2022 Jun; 54(6):730-738. PubMed ID: 35768579
[TBL] [Abstract][Full Text] [Related]
11. High expression of TMEM200A is associated with a poor prognosis and immune infiltration in gastric cancer.
Deng H; Li T; Wei F; Han W; Xu X; Zhang Y
Pathol Oncol Res; 2023; 29():1610893. PubMed ID: 36741965
[No Abstract] [Full Text] [Related]
12. BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates.
Zhao R; Peng C; Song C; Zhao Q; Rong J; Wang H; Ding W; Wang F; Xie Y
Int Immunopharmacol; 2020 Oct; 87():106828. PubMed ID: 32736193
[TBL] [Abstract][Full Text] [Related]
13. Increased IGFBP7 Expression Correlates with Poor Prognosis and Immune Infiltration in Gastric Cancer.
Zhao Q; Zhao R; Song C; Wang H; Rong J; Wang F; Yan L; Song Y; Xie Y
J Cancer; 2021; 12(5):1343-1355. PubMed ID: 33531979
[No Abstract] [Full Text] [Related]
14. Vil-Cre specific Slfn3KO mice exhibit sex-specific differences in lung, stomach, cecum, kidney, and proximal colon differentiation markers and Slfn family members expression levels.
Vomhof-DeKrey EE; Rajpathy OK; Preszler E; Basson MD
Biochem Biophys Rep; 2023 Dec; 36():101552. PubMed ID: 38076659
[TBL] [Abstract][Full Text] [Related]
15. Tumor Endothelial Marker TEM7 is a Prognostic Biomarker and Correlating with Immune Infiltrates in Gastric Cancer.
Geng L; Chen S; Gong Y; Zhou Y; Yang H; Tang L
Int J Gen Med; 2021; 14():10155-10171. PubMed ID: 34992436
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of NLRP1/NLRP3 and its relationship with immune infiltration in human gastric cancer.
Wang P; Gu Y; Yang J; Qiu J; Xu Y; Xu Z; Gao J; Wan C
Aging (Albany NY); 2022 Dec; 14(24):9980-10008. PubMed ID: 36541912
[TBL] [Abstract][Full Text] [Related]
17. LCP1 is a prognostic biomarker correlated with immune infiltrates in gastric cancer.
Zeng Q; Li L; Feng Z; Luo L; Xiong J; Jie Z; Cao Y; Li Z
Cancer Biomark; 2021; 30(1):105-125. PubMed ID: 32986657
[TBL] [Abstract][Full Text] [Related]
18. Expression and regulatory effects of murine Schlafen (Slfn) genes in malignant melanoma and renal cell carcinoma.
Mavrommatis E; Arslan AD; Sassano A; Hua Y; Kroczynska B; Platanias LC
J Biol Chem; 2013 Nov; 288(46):33006-15. PubMed ID: 24089532
[TBL] [Abstract][Full Text] [Related]
19. Identification and validation of the prognostic value of cyclic GMP-AMP synthase-stimulator of interferon (cGAS-STING) related genes in gastric cancer.
Yang KS; Xu CQ; Lv J
Bioengineered; 2021 Dec; 12(1):1238-1250. PubMed ID: 33843442
[TBL] [Abstract][Full Text] [Related]
20. The crucial role of single-stranded DNA binding in enhancing sensitivity to DNA-damaging agents for Schlafen 11 and Schlafen 13.
Fujiwara K; Maekawa M; Iimori Y; Ogawa A; Urano T; Kono N; Takeda H; Higashiyama S; Arita M; Murai J
iScience; 2023 Dec; 26(12):108529. PubMed ID: 38125019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
